Hong Kong Biotech Medicine B-Shares Surge Against Market, Songsy Biological, China Antibody, and Lepu Biochemical Rise Over 5%, Kolon Bio-Tech and Bio-Sight Chart Up Over 4%

July 31 message, Hong Kong biotech medicine B-shares surge against market, Songsy Biological, China Antibody, and Lepu Biochemical rise over 5%, Kolon Bio-Tech and Bio-Sight Chart up over 4%.

According to the National Medical Insurance Administration, on July 28, Vice Minister Li Tao met with the Singapore Government Investment Company (GIC) in Beijing, and both parties had in-depth exchanges on the relevant situations of medical insurance support for innovative drug development.

Li Tao indicated that in the next step, the National Medical Insurance Administration will continue to implement related policy measures and increase openness efforts, supporting the development of pharmaceutical companies, advancing medical technology, improving drug innovation, upgrading industry transformation, and welcoming domestic and foreign investment institutions to pay attention to China's innovative drugs, invest in China's innovative drugs, focus on health, and invest in health.